Oct 2024 - A snapshot of the stocks on the move, featuring Nanoveu (ASX:NVU), MoneyMe (ASX:MME) and Alicanto Minerals (ASX:AQI).

View All Immutep News. Immutep - Annual report to shareholders. 22 Oct 2024 01:10 PM. On behalf of the Board, I’m pleased to present Immutep Limiteds ...

Many of the mistakes investors make are based on common sense rules of thumb that turn out to be wrong. As a result, it’s often wise for investors to turn common sense logic on its head. The easiest ...

Oct 2024 - Viva Energy (ASX:VEA) posted solid sales growth for the third quarter of 2024, with group sales volumes rising by 3% year-on-year to 4.2 billion litres.

Mr James David Walker (Executive Chairman, Executive Director) ...

Oct 2024 - Praemium Limited (ASX:PPS) reported a robust start to FY25, with total Funds Under Administration (FUA) increasing by 33% to $59.4 billion as of 30 September 2024.

Oct 2024 - Next Science Limited (ASX:NXS), a Sydney-based medical technology company, has reported a 7% dip in product sales for the third quarter of FY24, generating US$4.7 million.

Oct 2024 - Immutep (ASX:IMM) has made significant progress over the past year with its lead immunotherapy candidate, eftilagimod alpha (efti).

Oct 2024 - Transurban (ASX:TCL) reported a 1.1% rise in average daily traffic (ADT) for the September 2024 quarter, reaching 2.5 million daily trips across its assets.

Oct 2024 - Mirvac Group (ASX:MGR) has made a strong start to FY25, driven by its residential and industrial segments and a $0.5 billion non-core asset sales program.

Vinyl Group (ASX:VNL) has announced a major commercial agreement with Songtradr, the world’s largest B2B music licensing platform.